Investor Relations

Sihuan Pharmaceutical Holdings Group Ltd. (“Sihuan Pharmaceutical” or the “Company”, together with its subsidiaries, the “Group”) (HKEX stock code: 0460) was founded in 2001 and listed on the Main Board of The Stock Exchange of Hong Kong Limited in 2010. It is an international pharmaceutical and medical aesthetics enterprise driven by innovation, with an independent and leading R&D platform, a diversified global product pipeline, strong product registration capabilities, highly efficient and cost-effective full-dose-form manufacturing platforms, and a mature, outstanding commercial system. Sihuan Pharmaceutical adheres to its strategy of advancing the dual-engine development of medical aesthetics and biopharmaceuticals at full speed to build a leading Chinese medical aesthetics and biopharmaceutical enterprise.